To investigate a relationship between maximum rectal diameter (MRD) on pre-treatment cone beam computed tomography (CBCT) and intra-fraction prostate motion, in the context of an adaptive image-guided radiotherapy (IGRT) method.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
The MRD was measured on 2125 CBCTs from 55 retrospective patient datasets and related to prostate displacement from intra-fraction imaging. A linear regression model was developed to determine a threshold MRD associated with a high probability of small prostate displacement. Standard and reduced adaptive margin plans were created to compare rectum and bladder normal tissue complication probability (NTCP) with each method.
A per-protocol analysis carried out on 1910 fractions from 51 patients showed with 90% confidence that for a MRD≤3 cm, prostate displacement will be ≤5 mm and that for a MRD≤3.5 cm, prostate displacement will be ≤5.5 mm. In the first scenario, if adaptive therapy was used instead of standard therapy, median reductions in NTCP for rectum and bladder were 0.5% (from 9.5% to 9%) and 1.3% (from 6.6% to 5.3%), respectively. In the second scenario, the NTCP for rectum and bladder would have median reductions of 1.1% and 2.6%, respectively.
We have identified a potential method for adaptive prostate IGRT based upon predicting small prostate intra-fraction motion by measuring MRD on pre-treatment CBCT.
Clinical oncology (Royal College of Radiologists (Great Britain)). 2016 Oct 22 [Epub ahead of print]
R Oates, A Brown, A Tan, F Foroudi, M Lim Joon, M Schneider, A Herschtal, T Kron
Radiation Therapy Services, Peter MacCallum Cancer Centre, Bendigo, Victoria, Australia; Medical Imaging & Radiation Sciences, Monash University, Melbourne, Victoria, Australia. Electronic address: ., Radiation Oncology, Townsville Cancer Centre, Townsville, Queensland, Australia., Radiation Oncology, Townsville Cancer Centre, Townsville, Queensland, Australia; College of Medicine and Dentistry, James Cook University, Queensland, Australia., Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Medical Imaging & Radiation Sciences, Monash University, Melbourne, Victoria, Australia., Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia; Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.